Tecfidera Slow-Titration Study
NCT02428231
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
62
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision
Conditions
Multiple Sclerosis
Interventions
DRUG:
dimethyl fumarate
Sponsor
Biogen